Skip to main content

OptiNose, Inc.

OPTNDelisted May 21, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001494650

OptiNose, Inc. was delisted on May 21, 2025; its insiders filed their last Form 4 on May 21, 2025; 43 institutions reported holding it in 13F filings for Q1 2025, worth $65.6M in total; no superinvestor held it.

Q2 2023 vs. Q1 2023

How the institutions holding OptiNose, Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of OPTN: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders6261−1
Shares62.4M72.6M+10.2M (+16.3%)
Value$120.2M$89.0M−$31.2M (−26.0%)

New holders (15)

Institutions that held OptiNose, Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to OPTN in Q2 2023
InstitutionSharesValue% of portfolio
Skandinaviska Enskilda Banken AB (publ)241,917$298.0K0.00%
Price T Rowe Associates Inc222,961$275.0K0.00%
Nuveen Asset Management, LLC102,190$125.7K0.00%
New York State Common Retirement Fund81,400$100.1K0.00%
Rhumbline Advisers62,377$76.7K0.00%
Invesco Ltd.39,046$48.0K0.00%
American International Group, Inc.35,095$43.2K0.00%
Virtu Financial LLC32,949$41.0K0.00%
California State Teachers Retirement System24,255$29.8K0.00%
ProShare Advisors LLC16,726$20.6K0.00%
Alliancebernstein L.P.13,700$16.9K0.00%
Amalgamated Bank11,055$14.0K0.00%
Legato Capital Management LLC10,799$13.3K0.00%
Legal & General Group Plc8,961$11.0K0.00%
Ameritas Investment Partners, Inc.6,021$7.41K0.00%

Sold out (16)

Institutions that held OptiNose, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.